Center for Translationel Forskning

Medicine & Life Sciences

1. Acetylcysteine 14%
2. alpha-Synuclein 28%
3. Antibodies 14%
4. Antioxidants 17%
5. Appetite Regulation 10%
6. Asthma 12%
7. BCG Vaccine 10%
8. Brain 16%
9. Case-Control Studies 12%
10. Chronic Obstructive Pulmonary Disease 35%
11. Clinical Studies 17%
12. Cognition 22%
13. Cognitive Dysfunction 16%
14. Cohort Studies 78%
15. Comorbidity 12%
16. Confidence Intervals 18%
17. Coronavirus 54%
18. Coronavirus Infections 14%
19. coronavirus receptor 14%
20. Cross-Over Studies 33%
21. Delivery of Health Care 17%
22. Denmark 81%
23. Dipeptidyl-Peptidase IV Inhibitors 10%
24. Dyspnea 15%
25. Early Warning Score 19%
26. Eating 11%
27. Equivalence Trials 10%
28. exendin (9-39) 13%
29. gastric inhibitory polypeptide receptor 16%
30. Gene Expression 10%
31. Geriatrics 11%
32. Glucagon 17%
33. Glucagon-Like Peptide 1 14%
34. Glucagon-Like Peptide-1 Receptor 44%
35. Glucokinase 10%
36. Glucose 42%
37. Glycocalyx 10%
38. Health Personnel 13%
39. Heart Failure 15%
40. Hepcidins 10%
41. Hospital Emergency Service 38%
42. Hospitalization 22%
43. Hydroxybutyrates 12%
44. Hyperglycemia 10%
45. Hyperoxia 32%
46. Hypoglycemia 26%
47. Hypoglycemic Agents 21%
48. Infections 17%
49. Insulin 14%
50. Ketone Bodies 18%
51. Ketones 23%
52. Liraglutide 11%
53. Mannose-Binding Lectin 21%
54. metabotropic glutamate receptor 2 12%
55. Mortality 43%
56. Multiple System Atrophy 26%
57. Muscle Strength 16%
58. Neurodegenerative Diseases 12%
59. Obesity 25%
60. Observational Studies 68%
61. Occupational Groups 18%
62. Oxygen 30%
63. Pandemics 22%
64. Parkinson Disease 20%
65. Parvalbumins 10%
66. Passive Immunization 12%
67. Peptides 21%
68. Perfusion Index 11%
69. Phenotype 12%
70. Placebos 51%
71. Polypharmacy 20%
72. Pragmatic Clinical Trials 13%
73. Prefrontal Cortex 13%
74. Prepulse Inhibition 13%
75. Prospective Studies 38%
76. Psoriatic Arthritis 19%
77. Quality of Life 23%
78. Randomized Controlled Trials 51%
79. Registries 12%
80. Respiratory Rate 13%
81. RNA 12%
82. Rural Hospitals 10%
83. SARS Virus 28%
84. Sensory Gating 22%
85. Sepsis 12%
86. Seroepidemiologic Studies 11%
87. Severe Acute Respiratory Syndrome 41%
88. Short Bowel Syndrome 10%
89. Sodium-Glucose Transport Proteins 19%
90. Synucleinopathies 23%
91. Synucleins 23%
92. Systematic Reviews 13%
93. Systemic Inflammatory Response Syndrome 13%
94. Therapeutics 18%
95. Transcutaneous Blood Gas Monitoring 12%
96. Type 1 Diabetes Mellitus 14%
97. Type 2 Diabetes Mellitus 100%
98. Vaccination 15%
99. Vital Signs 60%
100. Wounds and Injuries 11%